Clinical features and current treatment of diffuse malignant pleural mesothelioma Journal Article


Author: Rusch, V. W.
Article Title: Clinical features and current treatment of diffuse malignant pleural mesothelioma
Abstract: Malignant pleural mesothelioma is an uncommon cancer for which the major risk factor is prior asbestos exposure. During the past decade, there has been progress in the diagnosis, staging and biology of mesothelioma. Treatment remains controversial and ranges from supportive care alone to aggressive multimodality therapy. Prospective clinical trials in carefully staged patients are needed to determine what approaches to treatment may confer a survival benefit. © 1995, All rights reserved.
Keywords: cancer chemotherapy; cancer surgery; clinical trial; histopathology; cisplatin; doxorubicin; cancer risk; multimodality cancer therapy; antineoplastic agents; conference paper; cancer radiotherapy; combined modality therapy; treatment; cancer staging; staging; antineoplastic agent; lymphatic metastasis; neoplasm staging; carboplatin; cancer immunotherapy; radiotherapy; risk factors; tomography, x-ray computed; cyclophosphamide; vinblastine; immunotherapy; diagnosis; pleura mesothelioma; mesothelioma; vindesine; mitomycin; pleural neoplasms; clinical trials; azacitidine; clinical examination; asbestos; asbestosis; pleural mesothelioma; human; priority journal
Journal Title: Lung Cancer
Volume: 12
Issue: Suppl. 2
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 1995-06-01
Start Page: S127
End Page: S146
Language: English
DOI: 10.1016/s0169-5002(10)80011-x
PUBMED: 7551944
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 28 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    864 Rusch